Sapio Sciences and Ultima Genomics have announced a partnership aimed at accelerating genomics research.
The collaboration will make multiomics workflows more accessible and streamlined for researchers through the integration of Sapio’s AI-powered lab informatics solutions with Ultima’s high-throughput, low-cost sequencing platform.
Together, the companies hope to deliver efficient, traceable and unified workflows for multiomics research and clinical genomics.
Ultima Genomics is known for its innovative ultra-high throughput sequencing architecture, designed to reduce sequencing costs and scale beyond conventional technologies.
Its multiomics sequencing capabilities allow researchers to study layers of biology beyond DNA sequences alone. Many changes linked to disease occur first in other omic layers, such as in the epigenome in cancer.
Deeper levels of analysis are increasingly important for understanding complex biology, but until now have frequently required multiple costly assays and fragmented workflows.
This integration allows researchers and clinicians to combine Ultima’s data generation capabilities with Sapio’s analytics, automation and data management tools for a seamless, end-to-end solution.
Gilad Almogy, CEO and founder of Ultima Genomics, commented, “Partnering with Sapio Sciences aligns with our goals to enable leading sequencing labs and make genomic information more scalable."
"By integrating our high-throughput, low-cost sequencing platform with Sapio’s AI-powered lab informatics platform, we’re enabling a seamless, scalable solution for multiomics research and clinical genomics."
Almogy continued: “We’re excited to empower organisations to accelerate discovery, drive AI-powered insights and bring high-quality genomics into everyday workflows with unmatched efficiency and traceability.”
Key Benefits for customers include the following:
- Integrated workflows: unify sequencing and informatics into a single environment, so researchers avoid fragmented assays
- Lower cost per sample: reduce per-sample costs with ultra-high throughput sequencing
- Faster discovery cycles: accelerate discovery cycles with AI-driven analytics and automation
- Improved traceability: ensure compliance through end-to-end data provenance tracking
- Future-ready architecture: support genomics, transcriptomics, proteomics and other omics fields with a future-ready architecture.
“This partnership gives Ultima’s customers a direct path to combining world-class sequencing with equally powerful informatics,” said Andrew Wyatt, Chief Growth Officer at Sapio Sciences.
“By removing workflow complexity, we’re making it easier for labs to manage multiomics data, gain insights faster and scale without compromising quality or compliance.”
Sapio Sciences also has a Partner Programme (SSPP) that connects innovators with Sapio’s industry-leading lab informatics platform, fostering integrations that deliver measurable benefits to customers.
It includes the following three partner ecosystems:
- Technology partners: hardware, cloud and software vendors that extend the platform through integration, hosting and solution development
- Services partners: advisory and implementation experts who guide customers through lab automation and deployment.
- Reseller partners: value-added resellers (VARs) and consultants who resell Sapio solutions and add value through customisation, integration, training and support.